Albert Tran

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

Vlad Ratziu, Stephen A. Harrison, Sven Francque et al. · Gastroenterology · 2016 · 1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

Fabrice Carrat, Hélène Fontaine, Céline Dorival et al. · The Lancet · 2019 · 631 citations · Full text

Pharmacy, Pharmacotherapy, Outcomes Research +13

M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and nonalcoholic fatty liver disease

JingHong Wan, Merieme Benkdane, Fatima Teixeira-Clerc et al. · Hepatology · 2013 · 545 citations

Life Sciences, Cell Biology, Molecular Medicine +17

Increased Adipose Tissue Expression of Hepcidin in Severe Obesity Is Independent From Diabetes and NASH

Soumeya Bekri, Philippe Gual, Rodolphe Anty et al. · Gastroenterology · 2006 · 491 citations

Medicine, Biochemistry, Molecular Medicine +12

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890

Christophe Hézode, Hélène Fontaine, Céline Dorival et al. · Journal of Hepatology · 2013 · 431 citations

Pharmacy, Internal Medicine, Pharmacotherapy +12